跳至主要内容
临床试验/ACTRN12617001408370
ACTRN12617001408370进行中(未招募)未知

Exercise as a diagnostic and therapeutic tool for the prevention of cardiovascular morbidity in breast cancer survivors - a randomised trial

Baker Heart and Diabetes Institute0 个研究点目标入组 103 人开始时间: 2017年10月5日最近更新:
适应症

试验速览

阶段
未知
状态
进行中(未招募)
入组人数
103

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
40 Years 至 75 Years(—)
性别
Female

入选标准

  • Women aged 40-75 years who have been diagnosed with breast cancer and are scheduled to undergo anthracycline-based chemotherapy will be eligible to participate in the study. All eligible participants must also obtain medical approval from their physician before participating.

排除标准

  • Participants will be excluded if they (1) have known structural heart disease (such as symptomatic ischemic heart disease, significant valvular disease or inherited cardiomyopathies), (2) have contraindications to the CMR procedure (pacemakers, implanted metallic foreign body or device), (3) have the presence of any serious contraindication or uncontrolled medical condition that would limit participation in the exercise program, (4) an inability to complete questionnaires in english language or (5) significant cognitive impairment.

研究者

相似试验